Jihun Lee

Jihun Lee

Auto-generated profile, based on publicly available information

Jihun Lee

Celltrion Inc

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Cell
Verified
Journal Article
Closed access
AMAmandine Molliex
Amandine Molliex
JTJamshid Temirov
Jamshid Temirov
JLJihun Lee
Jihun Lee
MCMaura Coughlin
Maura Coughlin
AKAnderson P. Kanagaraj
Anderson P. Kanagaraj
JTJ. Paul Taylor
J. Paul Taylor

12 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
CKCheolmin Kim
Cheolmin Kim
DRDong-Kyun Ryu
Dong-Kyun Ryu
JLJihun Lee
Jihun Lee
YKYoung-Il Kim
Young-Il Kim
JSJi-Min Seo
Ji-Min Seo
SLSoo-Young Lee
Soo-Young Lee
Vaccines and therapeutics are urgently needed for the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we screen human monoclonal antibodies (mAb) targeting the receptor binding domain (RBD) of the viral spike protein via antibody library constructed from peripheral blood mononuclear cells of a convalescent patient. The CT-P59 mAb potently neutralizes SARS-CoV-2 isolates including the D614G variant without antibody-dependent enhancement effect. Complex crystal structure of CT-P59 Fab/RBD shows that CT-P59 blocks interaction regions of RBD for angiotensin converting enzyme 2 (ACE2) receptor with an orientation that is notably different from previously reported RBD-targeting mAbs. Furthermore, therapeutic effects of CT-P59 are evaluated in three animal models (ferret, hamster, and rhesus monkey), demonstrating a substantial reduction in viral titer along with alleviation of clinical symptoms. Therefore, CT-P59 may be a promising therapeutic candidate for COVID-19.

24 May 2016 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MMMelissa R Marzahn
Melissa R Marzahn
SMSuresh Marada
Suresh Marada
JLJihun Lee
Jihun Lee
ANAmanda Nourse
Amanda Nourse
SKSophia Kenrick
Sophia Kenrick
TMTanja Mittag
Tanja Mittag
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 November 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
HYHyesook Yoon
Hyesook Yoon
GLGurunathan Laxmikanthan
Gurunathan Laxmikanthan
JLJihun Lee
Jihun Lee
SBSachiko I. Blaber
Sachiko I. Blaber
ARAaron Rodriguez
Aaron Rodriguez
MBMichael Blaber
Michael Blaber
The human kallikrein (KLK)-related peptidases are the largest family of serine peptidases, comprising 15 members (KLK1–15) and with the majority (KLK4–15) being identified only within the last decade. Members of this family are associated with important diseased states (including cancer, inflammation, and neurodegeneration) and have been utilized or proposed as clinically important biomarkers or therapeutic targets of interest. All human KLKs are synthesized as prepro-forms that are proteolytically processed to secreted pro-forms via the removal of an amino-terminal secretion signal peptide. The secreted inactive pro-KLKs are then activated extracellularly to mature peptidases by specific proteolytic release of their amino-terminal propeptide. Although a key step in the regulation of KLK function, details regarding the activation of the human pro-KLKs (i.e. the KLK “activome”) are unknown, to a significant extent, but have been postulated to involve “activation cascades” with other KLKs and endopeptidases. To characterize more completely the KLK activome, we have expressed from Escherichia coli individual KLK propeptides fused to the amino terminus of a soluble carrier protein. The ability of 12 different mature KLKs to process the 15 different pro-KLK peptide sequences has been determined. Various autolytic and cross-activation relationships identified using this system have subsequently been characterized using recombinant pro-KLK proteins. The results demonstrate the potential for extensive KLK activation cascades and, when combined with available data for the tissue-specific expression of the KLK family, permit the construction of specific regulatory cascades. One such tissue-specific cascade is proposed for the central nervous system.

22 January 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
LLLiam Longo
Liam Longo
JLJihun Lee
Jihun Lee
MBMichael Blaber
Michael Blaber
A compendium of different types of abiotic chemical syntheses identifies a consensus set of 10 “prebiotic” α-amino acids. Before the emergence of biosynthetic pathways, this set is the most plausible resource for protein formation (i.e., proteogenesis) within the overall process of abiogenesis. An essential unsolved question regarding this prebiotic set is whether it defines a “foldable set”—that is, does it contain sufficient chemical information to permit cooperatively folding polypeptides? If so, what (if any) characteristic properties might such polypeptides exhibit? To investigate these questions, two “primitive” versions of an extant protein fold (the β-trefoil) were produced by top-down symmetric deconstruction, resulting in a reduced alphabet size of 12 or 13 amino acids and a percentage of prebiotic amino acids approaching 80%. These proteins show a substantial acidification of pI and require high salt concentrations for cooperative folding. The results suggest that the prebiotic amino acids do comprise a foldable set within the halophile environment.

20 December 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JLJihun Lee
Jihun Lee
MBMichael Blaber
Michael Blaber
The majority of protein architectures exhibit elements of structural symmetry, and “gene duplication and fusion” is the evolutionary mechanism generally hypothesized to be responsible for their emergence from simple peptide motifs. Despite the central importance of the gene duplication and fusion hypothesis, experimental support for a plausible evolutionary pathway for a specific protein architecture has yet to be effectively demonstrated. To address this question, a unique “top-down symmetric deconstruction” strategy was utilized to successfully identify a simple peptide motif capable of recapitulating, via gene duplication and fusion processes, a symmetric protein architecture (the threefold symmetric β-trefoil fold). The folding properties of intermediary forms in this deconstruction agree precisely with a previously proposed “conserved architecture” model for symmetric protein evolution. Furthermore, a route through foldable sequence-space between the simple peptide motif and extant protein fold is demonstrated. These results provide compelling experimental support for a plausible evolutionary pathway of symmetric protein architecture via gene duplication and fusion processes.